These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31526283)

  • 21. Assessment value of interleukin-6, procalcitonin, and C-reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective study.
    Zheng H; Luo Z; Yi Y; Liu K; Huo Z; You Y; Li H; Tang M
    Cancer Med; 2024 Jul; 13(13):e7307. PubMed ID: 38967137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin and C-reactive protein in differantiating to contamination from bacteremia.
    Oksuz L; Somer A; Salman N; Erk O; Gurler N
    Braz J Microbiol; 2014; 45(4):1415-21. PubMed ID: 25763049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis.
    Wu CW; Wu JY; Chen CK; Huang SL; Hsu SC; Lee MT; Chang SS; Lee CC
    Support Care Cancer; 2015 Oct; 23(10):2863-72. PubMed ID: 25701436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation.
    Michel CS; Teschner D; Wagner EM; Theobald M; Radsak MP
    Ann Hematol; 2017 Dec; 96(12):2095-2101. PubMed ID: 28920169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.
    Halder R; Seth T; Chaturvedi PK; Mishra P; Mahapatra M; Pati HP; Tyagi S; Saxena R
    Blood Cells Mol Dis; 2020 Sep; 84():102445. PubMed ID: 32480243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria.
    Liu HH; Zhang MW; Guo JB; Li J; Su L
    Ir J Med Sci; 2017 Feb; 186(1):207-212. PubMed ID: 27139197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenomedullin--A New Marker in Febrile Neutropenia: Comparison With CRP and Procalcitonin.
    Demirkaya M; Tugcu D; Akcay A; Aydogan G; Akıcı F; Salcioglu Z; Ekmekci H; Sevinir B; Balci Ekmekci O
    Pediatr Hematol Oncol; 2015; 32(7):482-9. PubMed ID: 26271020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procalcitonin as a Marker of Bacteremia in Patients With Fever and Acute Lymphoblastic Leukemia.
    Vyles D; Gnagi F; Bulloch B; Muenzer J; Hu C
    Pediatr Emerg Care; 2016 Sep; 32(9):590-3. PubMed ID: 26785096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of Procalcitonin, C-reactive protein-to-lymphocyte ratio (CLR), C-reactive protein and neutrophil-to-lymphocyte ratio (NLR) for predicting patients with Bacteraemia in the intensive care unit.
    Zhang GM; Gu YY
    J Crit Care; 2024 Jun; 81():154538. PubMed ID: 38354622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.
    Koh H; Aimoto M; Katayama T; Hashiba M; Sato A; Kuno M; Makuuchi Y; Takakuwa T; Okamura H; Hirose A; Nakamae M; Hino M; Nakamae H
    J Infect Chemother; 2016 Jul; 22(7):466-71. PubMed ID: 27184936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of the kinetics of procalcitonin and C-reactive protein for early clinical stability in patients with bloodstream infections due to Gram-negative bacteria.
    Gutiérrez-Gutiérrez B; Morales I; Pérez-Galera S; Fernández-Riejos P; Retamar P; de Cueto M; Pascual Á; Rodríguez-Baño J
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):63-68. PubMed ID: 30131239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.
    García de Guadiana-Romualdo L; Español-Morales I; Cerezuela-Fuentes P; Consuegra-Sánchez L; Hernando-Holgado A; Esteban-Torrella P; Jiménez-Santos E; Viqueira-González M; de Béjar-Almira Á; Albaladejo-Otón MD
    Support Care Cancer; 2015 Jul; 23(7):2175-82. PubMed ID: 25564222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin as a marker of Gram-negative bloodstream infections in hematological patients with febrile neutropenia.
    Luo X; Chen S; Zhang J; Ren J; Chen M; Lin K; Zhu H; Zheng R; Zheng Z; Chen Z; Hu J; Yang T
    Leuk Lymphoma; 2019 Oct; 60(10):2441-2448. PubMed ID: 30806111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis.
    Kocazeybek B; Küçükoğlu S; Oner YA
    Chemotherapy; 2003 May; 49(1-2):76-84. PubMed ID: 12714816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteremia detection from complete blood count and differential leukocyte count with machine learning: complementary and competitive with C-reactive protein and procalcitonin tests.
    Lien F; Lin HS; Wu YT; Chiueh TS
    BMC Infect Dis; 2022 Mar; 22(1):287. PubMed ID: 35351003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics.
    Koizumi Y; Sakanashi D; Ohno T; Nakamura A; Yamada A; Shibata Y; Shiota A; Kato H; Hagihara M; Asai N; Watarai M; Murotani K; Yamagishi Y; Suematsu H; Mikamo H
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1028-1037. PubMed ID: 32893142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.
    Jimeno A; García-Velasco A; del Val O; González-Billalabeitia E; Hernando S; Hernández R; Sánchez-Muñoz A; López-Martín A; Durán I; Robles L; Cortés-Funes H; Paz-Ares L
    Cancer; 2004 Jun; 100(11):2462-9. PubMed ID: 15160353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
    Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia.
    Gac AC; Parienti JJ; Chantepie S; Fradin S; Le Coutour X; Leclercq R; Reman O
    Leuk Res; 2011 Oct; 35(10):1294-6. PubMed ID: 21831426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance enhancement of procalcitonin by high-sensitivity C-reactive protein at the optimal cutoff in predicting bacteremia in emergency department adult patients.
    Kok VC; Lin CT; Yeh CB; Yang CC; Horng JT
    Scand J Clin Lab Invest; 2019; 79(1-2):25-31. PubMed ID: 30628465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.